Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer.

Cancer investigation - 1 Jan 2001

Yazici H, Altun M, Hafiz G, Dalay N

Abstract excerpt

To date there are no prognostic factors that can account for the biology and disease behavior in nasopharyngeal cancer. Therefore, identification of new factors that can help in predicting the behavior of the disease and characterizing the subgroup with more aggressive tumors more likely to benefitfrom chemotherapy is important. In this study, c-erb B2, bcl-2, and mutant p53 protein levels were investigated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nasopharyngeal Neoplasms

Share to Proto-Oncogene Proteins c-bcl-2

Share to Receptor, ErbB-2

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 11768029
DOI: 10.1081/cnv-100107737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer.PMID 11768029Read ↗

Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.Semantic proximity Read ↗

The bcl-2 gene status of human head and neck cancer cell lines.Semantic proximity Read ↗

Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.Semantic proximity Read ↗

Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.Semantic proximity Read ↗

Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.Semantic proximity Read ↗

The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.Semantic proximity Read ↗

p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis.Semantic proximity Read ↗

bcl-2 Protein in Non-Small-Cell Lung CarcinomaSemantic proximity Read ↗

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomasSemantic proximity Read ↗

Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.Semantic proximity Read ↗

Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.